SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-17-002319
Filing Date
2017-06-08
Accepted
2017-06-08 16:11:38
Documents
7
Period of Report
2017-06-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c88571_8k.htm 8-K 16216
2 c88571_ex99-1.htm EX-99.1 113093
3 GRAPHIC x2_c88571a003.jpg GRAPHIC 2649
4 GRAPHIC x2_c88571a004.jpg GRAPHIC 2679
5 c88571_ex99-2.htm EX-99.2 9372
6 GRAPHIC x2_c88571a001.jpg GRAPHIC 5408
7 GRAPHIC x2_c88571a002.jpg GRAPHIC 5009
  Complete submission text file 0000930413-17-002319.txt   162146
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 17900341
SIC: 8071 Services-Medical Laboratories